Literature DB >> 34724240

Safety of intravenous arginine therapy in children with sickle cell disease hospitalized for vaso-occlusive pain: A randomized placebo-controlled trial in progress.

Loretta Z Reyes1,2, Janet Figueroa1,2, Deborah Leake2, Kirshma Khemani1,2, Polly Kumari1,2, Nitya Bakshi1,2, Peter A Lane1,2, Carlton Dampier1,2, Claudia R Morris1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34724240      PMCID： PMC8722015          DOI： 10.1002/ajh.26396

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

2.  Randomized control trial of oral arginine therapy for children with sickle cell anemia hospitalized for pain in Nigeria.

Authors:  Richard Onalo; Peter Cooper; Antoinette Cilliers; Barend C Vorster; Nnebe-Agumadu Uche; Oniyangi O Oluseyi; Victoria D Onalo; Yunusa Zubairu; Alice U Ayodele-Kehinde; Oladimeji M Damilare; Janet Figueroa; Claudia R Morris
Journal:  Am J Hematol       Date:  2020-11-20       Impact factor: 10.047

3.  Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.

Authors:  Claudia R Morris; Lou Ann S Brown; Michael Reynolds; Carlton D Dampier; Peter A Lane; Amanda Watt; Polly Kumari; Frank Harris; Shaminy Manoranjithan; Reshika D Mendis; Janet Figueroa; Sruti Shiva
Journal:  Blood       Date:  2020-09-17       Impact factor: 22.113

4.  The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database.

Authors:  Sophie Lanzkron; C Patrick Carroll; Carlton Haywood
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

5.  Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.

Authors:  C R Morris; F A Kuypers; S Larkin; E P Vichinsky; L A Styles
Journal:  J Pediatr Hematol Oncol       Date:  2000 Nov-Dec       Impact factor: 1.289

6.  A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.

Authors:  Claudia R Morris; Frans A Kuypers; Lisa Lavrisha; Michael Ansari; Nancy Sweeters; Melinee Stewart; Ginny Gildengorin; Lynne Neumayr; Elliott P Vichinsky
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941
  6 in total
  1 in total

1.  L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic.

Authors:  Pasquale Mone; Raffaele Izzo; Giuseppe Marazzi; Maria Virginia Manzi; Paola Gallo; Giuseppe Campolongo; Luca Cacciotti; Domenico Tartaglia; Giuseppe Caminiti; Fahimeh Varzideh; Gaetano Santulli; Valentina Trimarco
Journal:  J Pharmacol Exp Ther       Date:  2022-03-26       Impact factor: 4.402
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.